Biomerica (BMRA) Cash from Operations Growth (1y) (2011 - 2026)
Biomerica (BMRA) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 6.69% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -84.38% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 16.00% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.43% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 185.96% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 28.60% |
| 10 | Biomerica | 6.20 Mn | 4.87 Mn | -44,000.00 | -19.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -19.62% |
| Nov 30, 2025 | -25.28% |
| Aug 31, 2025 | 80.06% |
| May 31, 2025 | 36.69% |
| Feb 28, 2025 | 41.98% |
| Nov 30, 2024 | 6.06% |
| Aug 31, 2024 | 19.71% |
| May 31, 2024 | -8.41% |
| Feb 29, 2024 | -4.41% |
| Nov 30, 2023 | 30.59% |
| Aug 31, 2023 | -6.42% |
| May 31, 2023 | 77.37% |
| Feb 28, 2023 | -173.15% |
| Nov 30, 2022 | 57.89% |
| Aug 31, 2022 | -2,174.21% |
| May 31, 2022 | -322.36% |
| Feb 28, 2022 | 272.92% |
| Nov 30, 2021 | -124.48% |
| Aug 31, 2021 | 104.75% |
| May 31, 2021 | 71.16% |